Autonomix Medical (AMIX) Stock: Buy, Sell, or Hold?
AMIX - Autonomix Medical, Inc. Common Stock
$2.54
-0.03 (-1.17%)
βΌ
5d:
-13.31%
30d:
-36.18%
90d:
-13.01%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 11, 2026
19d
Get Alerted When AMIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: AMIX is down 13.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: AMIX is down 13.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: AMIX is currently trading at $2.54, which is considered oversold relative to its 30-day fair value range of $2.95 to $4.11.
Technical Outlook: Technically, AMIX is showing sideways momentum. The price is currently testing key support at $2.56. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $40.80 (+1487.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AMIX is showing sideways momentum. The price is currently testing key support at $2.56. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $40.80 (+1487.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.95 -
$4.11
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1487.5% below Wall St target ($40.80)
- WARNING: Composite score 47/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.95 -
$4.11
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.56
Resistance Level
$3.40
Current Trend
Sideways
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.58
Wall Street Target
$40.80
(+1487.5%)
Share & Embed Analysis
Last updated: October 22, 2026 1:57 PM ET
Data refreshes hourly during market hours. Next update: 2:57 PM
Data refreshes hourly during market hours. Next update: 2:57 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AMIX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 49 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
29 analysts |
$363 | 32 SELL |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 44 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 73 BUY |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
15 analysts |
$171 | 48 HOLD |